Occupation was lay user/patient.Unique device identifier (udi) (b)(4).The suspected products were requested to be returned for investigation, however, the strips were no longer available to return.Routine retention testing is performed.Retention testing data is reviewed and appropriate actions are taken as needed.Test strip retention samples passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.".
|
We received a report of questionable results obtained on a coaguchek xs meter serial number (b)(4), compared to laboratory results utilizing an unknown analyzer and reagent.The meter result was 4.0 inr at 10:17 am.The laboratory result was 2.6 inr taken at approximately 2:00 pm.A second set of results was taken on (b)(6) 2021: the meter result was 4.3 inr at 9:48 am.The laboratory result was 3.0 inr taken at approximately 11:35 am.The laboratory results were believed on both days.The patient's therapeutic range was 2.3-3.5 inr, and the testing interval was every two weeks.
|